EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-4.3%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.81B
AUM Growth
+$135M
(+2.4%)
Cap. Flow
+$429M
Cap. Flow
% of AUM
7.38%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
954
New
28
Increased
196
Reduced
108
Closed
52
Top Buys
| 1 |
Visa
V
|
$50.7M |
| 2 |
PACCAR
PCAR
|
$42.4M |
| 3 |
KLA
KLAC
|
$35.7M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$35.1M |
| 5 |
Amazon
AMZN
|
$21.8M |
Top Sells
| 1 |
Marriott International Class A Common Stock
MAR
|
$51.9M |
| 2 |
Abbott
ABT
|
$28.5M |
| 3 |
Pfizer
PFE
|
$27.1M |
| 4 |
Viasat
VSAT
|
$18M |
| 5 |
Qualcomm
QCOM
|
$14.1M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 18.76% |
| 3 | Financials | 9.65% |
| 4 | Consumer Discretionary | 9.57% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Amphenol
APH
$135B
| $1.52M | 0.03% |
36,280
-9,800
| -21% | -$412K |
|
302
Sun Life Financial
SLF
$32.4B
| $1.49M | 0.03% |
30,500
| – | – |
|
|
303
Qualcomm
QCOM
$172B
| $1.47M | 0.03% |
13,334
-127,484
| -91% | -$14.1M |
|
304
Vaxcyte
PCVX
$4.29B
| $1.46M | 0.03% |
29,000
| – | – |
|
305
Carrier Global
CARR
$55.8B
| $1.44M | 0.02% |
25,700
| – | – |
|
306
Pinduoduo
PDD
$177B
| $1.43M | 0.02% |
+15,000
| New | +$1.43M |
|
307
Stride
LRN
$7.01B
| $1.41M | 0.02% |
31,100
| – | – |
|
308
Global Payments
GPN
$21.3B
| $1.41M | 0.02% |
12,125
+201
| +2% | +$23.3K |
|
309
Zoetis
ZTS
$67.9B
| $1.39M | 0.02% |
8,014
+1,246
| +18% | +$217K |
|
310
Amicus Therapeutics
FOLD
$2.46B
| $1.39M | 0.02% |
116,850
| – | – |
|
311
Sempra
SRE
$52.9B
| $1.38M | 0.02% |
20,366
+298
| +1% | +$20.2K |
|
312
Simon Property Group
SPG
$59.5B
| $1.37M | 0.02% |
12,600
-500
| -4% | -$54.4K |
|
313
Goldman Sachs
GS
$223B
| $1.35M | 0.02% |
4,149
+66
| +2% | +$21.5K |
|
314
Chemours
CC
$2.34B
| $1.3M | 0.02% |
46,666
+681
| +1% | +$18.9K |
|
315
Banco Bradesco
BBD
$33.6B
| $1.3M | 0.02% |
458,253
| – | – |
|
|
BPMC
316
DELISTED
Blueprint Medicines
BPMC
| $1.28M | 0.02% |
25,100
| – | – |
|
317
Manulife Financial
MFC
$52.1B
| $1.27M | 0.02% |
68,900
| – | – |
|
318
Phillips 66
PSX
$53.2B
| $1.27M | 0.02% |
+10,300
| New | +$1.27M |
|
319
DexCom
DXCM
$31.6B
| $1.27M | 0.02% |
13,308
+3,200
| +32% | +$305K |
|
320
Cheniere Energy
LNG
$51.8B
| $1.27M | 0.02% |
7,495
-14,223
| -65% | -$2.4M |
|
|
ITCI
321
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.26M | 0.02% |
23,400
| – | – |
|
322
Xenon Pharmaceuticals
XENE
$3.02B
| $1.24M | 0.02% |
35,000
| – | – |
|
323
Insmed
INSM
$30.7B
| $1.23M | 0.02% |
47,600
| – | – |
|
324
MasTec
MTZ
$14B
| $1.21M | 0.02% |
16,589
+233
| +1% | +$17K |
|
325
Crown Castle
CCI
$41.9B
| $1.2M | 0.02% |
13,076
-700
| -5% | -$64.5K |
|